ClinicalTrials.Veeva

Menu

Efficacy of Magnetotherapy in Hand Erosive Osteoarthritis.

H

Hospital Mutua de Terrassa

Status

Completed

Conditions

Musculoskeletal Pain
Musculoskeletal Disease
Physical Therapy

Treatments

Device: Magnetotherapy device
Device: Placebo

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Erosive arthritis (EA) is an unusual pathology. There is no definitive treatment and the conventional one has little efficacy. Despite using magnetotherapy (MGT) as a treatment, there is no evidence supporting its use.

Full description

The aim of the study is to evaluate the efficacy of MGT in patients suffering from hand EA, compared to placebo, in terms of pain (assessed by Visual Analog Scale (VAS)) and functionality (assessed by The Disabilities of the Arm, Shoulder and Hand (DASH) score) during the treatment and after a 3-months period. Secondarily, rigidity (Modified Kapandji Index), grip strength (JAMAR dynamometry) and quality of life (SF-36 questionnaire) were assessed. Treatment safety will also be evaluated.

Enrollment

19 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients of both sexes older than 18 years with symptomatic hand erosive osteoarthritis for more than 6 months.
  • Patients receiving treatment or not for their hand pathology.
  • Patients suffering from hand chronic pain due to their pathology and scoring VAS equal or greater than 4/10.
  • Patients who voluntarily signed the informed consent and agree to participate in the study.

Exclusion criteria

  • Pregnancy
  • Patients with pacemaker or similar devices
  • Pacients with cognitive dysfunction.
  • Patients with psychiatric pathologies unable to comply with the treatment and follow-up
  • Patients with active oncological and / or infectious pathology
  • Patients with previous magnetotherapy or paraffin treatment in the last year

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

19 participants in 2 patient groups, including a placebo group

Intervention group
Experimental group
Description:
Treatment with magnetotherapy device 15 20-minute-sesions every consecutive working day.
Treatment:
Device: Magnetotherapy device
Control group placebo
Placebo Comparator group
Description:
Treatment with misconnected magnetotherapy device 15 20-minute-sesions every consecutive working day.
Treatment:
Device: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems